Research Advances in Lipid Metabolic Reprogramming Mechanisms of Colorectal Cancer Cells
Authors:
Open Access
- 20 August 2025
- journal article
- Published by ConnectSix Scholar Publishing INC in Advances in World Medical Research
- Vol. 1 (2) , 26-47
Abstract
Colorectal cancer (CRC) is a highly aggressive form of cancer that poses a significant threat to public health worldwide. The progression of this disease is primarily driven by metabolic changes, especially the disruption of lipid metabolism. Cancerous CRC cells proliferate uncontrollably and invade surrounding tissues due to abnormal modifications in fatty acid synthesis, lipid uptake, storage, and β-oxidation. These metabolic shifts are influenced by key oncogenic signaling pathways, such as the PI3K/AKT/mTOR pathway and the MYC transcriptional network, which also enhance interactions with the tumor microenvironment's stromal elements. Recent research suggests that targeting lipid metabolism through pharmacological means could offer substantial clinical benefits. This article provides a comprehensive analysis of the molecular mechanisms involved in the reprogramming of lipid metabolism in CRC development and assesses its potential for innovative therapeutic approaches.Keywords
This publication has 98 references indexed in Scilit:
- Glycerol‐3‐phosphate acyltransferase 3‐mediated lipid droplets accumulation confers chemoresistance of colorectal cancerMedcomm, 2024
- Multitarget Stool RNA Test for Colorectal Cancer ScreeningJAMA, 2023
- Role of cancer-associated fibroblasts in colorectal cancer and their potential as therapeutic targetsBiochemical and Biophysical Research Communications, 2023
- Integrating TCGA and single-cell sequencing data for colorectal cancer: a 10-gene prognostic risk assessment modelDiscover Oncology, 2023
- Targeting lipid metabolism with natural products: A novel strategy for gastrointestinal cancer therapyPhytotherapy Research, 2023
- Lipid metabolism reprogramming in colorectal cancerJournal of Cellular Biochemistry, 2022
- Spermine synthesis inhibitor blocks 25-hydroxycholesterol-induced- apoptosis via SREBP2 upregulation in DLD-1 cell spheroidsBiochemistry and Biophysics Reports, 2020
- Berberine suppresses colon cancer cell proliferation by inhibiting the SCAP/SREBP-1 signaling pathway-mediated lipogenesisBiochemical Pharmacology, 2020
- Shotgun lipidomics-based characterization of the landscape of lipid metabolism in colorectal cancerBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2020
- Hallmarks of Cancer: The Next GenerationCell, 2011